CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma

Aberrant chromobox (CBX) family protein expression has been reported in a variety of human malignancies. However, the role of CBX6 in hepatocellular carcinoma (HCC) progression and patient prognosis remains unknown. In this study, we found that CBX6 was frequently up-regulated in HCC clinical sample...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Hao, Jiang, Wei-hua, Tian, Tao, Tan, Hai-song, Chen, Ying, Qiao, Guang-lei, Han, Jun, Huang, Sheng-yu, Yang, Yuan, Li, Shuai, Wang, Zhen-guang, Gao, Rong, Ren, Hao, Xing, Hao, Ni, Jun-sheng, Wang, Lin-Hui, Ma, Li-jun, Zhou, Wei-ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386654/
https://www.ncbi.nlm.nih.gov/pubmed/28122351
http://dx.doi.org/10.18632/oncotarget.14770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386654/
https://www.ncbi.nlm.nih.gov/pubmed/28122351
http://dx.doi.org/10.18632/oncotarget.14770

Ejemplares similares